Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TIGIT (Tiragolumab Biosimilar) antibody

Reactivity: Human ELISA, FACS, BLI, Func, SPR Host: Human Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7581704
  • Target See all TIGIT (Tiragolumab Biosimilar) products
    TIGIT (Tiragolumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    • 1
    Human
    Expression System
    CHO Cells
    Clonality
    • 2
    Monoclonal
    Conjugate
    • 2
    This TIGIT (Tiragolumab Biosimilar) antibody is un-conjugated
    Application
    ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
    Purpose
    Anti-TIGIT Reference Antibody (tiragolumab)
    Sequence
    EVQLQQSGPG LVKPSQTLSL TCAISGDSVS SNSAAWNWIR QSPSRGLEWL GKTYYRFKWY SDYAVSVKGR ITINPDTSKN QFSLQLNSVT PEDTAVFYCT RESTTYDLLA GPFDYWGQGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIVMTQSPDS LAVSLGERAT INCKSSQTVL YSSNNKKYLA WYQQKPGQPP NLLIYWASTR ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQQYYST PFTFGPGTKV EIKRTVAAPS VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
    Characteristics
    Anti-TIGIT Reference Antibody (tiragolumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
    Purity
    >95 %
    Isotype
    IgG1
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Therapeutic Agents by Target and Mechanism: TIGIT inhibitors

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    1 mg/mL
    Buffer
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    Storage
    4 °C,-80 °C
    Storage Comment
    +4°C,-80°C
  • Target
    TIGIT (Tiragolumab Biosimilar)
    Abstract
    TIGIT (Tiragolumab Biosimilar) Products
    Target Type
    Biosimilar
    Molecular Weight
    145.5 kDa
    UniProt
    Q495A1
You are here:
Support